22. August 2017. | VACCINES

Indian patent office delivers major blow to affordable pneumonia vaccine hopes

Indian patent office granted a patent to Pfizer for its PCV13 product, marketed as Prevnar13. The granting of this patent would block other manufacturers in India from supplying this vaccine until 2026. Read more